Methods and nucleic acid molecules for aav vector selection
US-2024417717-A1 · Dec 19, 2024 · US
US2016018397A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016018397-A1 |
| Application number | US-201414332060-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 15, 2014 |
| Priority date | Jul 15, 2013 |
| Publication date | Jan 21, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides recombinant phages, a Wip1 p23 receptor binding protein and a Wip1 p24 receptor binding protein that bind to Bacillus anthracis . The disclosure further provides methods and uses thereof.
Opening claim text (preview).
We claim: 1 . A recombinant protein composition comprising Wip1 p23 receptor binding protein, variants or fragments thereof. 2 . The recombinant protein composition according to claim 1 , wherein the recombinant protein composition further comprises Wip1 p24 receptor binding protein, variants or fragments thereof. 3 . The recombinant protein composition according to claim 1 , wherein the Wip1 p23 receptor binding protein further comprises a reporter molecule. 4 . The recombinant protein composition according to claim 4 , wherein the reporter molecule is a fluorophore, a fluorophore/quencher pair, an antibody, a llama-body, an isotope, or combinations thereof. 5 . The recombinant protein composition according to claim 1 , wherein the Wip1 p23 receptor binding protein is capable of binding Bacillus anthracis. 6 . The recombinant protein composition according to claim 1 , further comprising a substrate. 7 . The recombinant protein composition according to claim 1 , wherein the substrate is an array. 8 . A system for detecting Bacillus anthracis comprising a recombinant protein composition according to claim 1 , and a detector in communication with said recombinant protein composition, wherein the detector is capable of detecting a signal generated upon recognition of a Bacillus anthracis receptor by the recombinant protein composition. 9 . The system according to claim 8 , further comprising a light source in optical communication with the recombinant protein composition. 10 . The system according to claim 8 , further comprising a processor for processing signals detected by the detector. 11 . A method of identifying or detecting Bacillus anthracis in a sample, the method comprising: (a) providing a sample suspected of containing Bacillus anthracis ; (b) contacting the sample with a recombinant protein composition according to claim 1 , wherein a change in a signal generated by a reporter molecule indicates the presence of Bacillus anthracis in the sample. 12 . The method according to claim 11 , wherein the sample is a biological sample or environmental sample. 13 . The method according to claim 11 , wherein the reporter molecule is a fluorophore or flurophore/quencher pair. 14 . The method according to claim 11 , wherein the recombinant protein composition changes conformation when contacting a Bacillus anthracis receptor thereby changing detectable properties of the recombinant protein composition. 15 . An isolated nucleic acid encoding a Wip1 p23 receptor binding protein, a Wip1 p24 receptor binding protein, a variant thereof, or combination thereof, wherein the Wip1 p23 receptor binding protein, Wip1 p24 receptor binding protein, variants or combinations thereof bind to Bacillus anthracis. 16 . The isolated nucleic acid according to claim 15 , wherein the isolated nucleic acid is operably linked to a regulatory element, reporter, a detectable element, or combinations thereof. 17 . The isolated nucleic acid according to claim 15 , wherein the isolated nucleic acid is a cDNA. 18 . A recombinant expression vector comprising the isolated nucleic acid according to claim 15 . 19 . A recombinant expression composition comprising recombinant expression vector according to claim 18 . 20 . The recombinant expression composition according to claim 19 , wherein the recombinant expression composition further comprises a detectable element.
from viruses · CPC title
Bacteria · CPC title
Assays involving receptors, cell surface antigens or cell surface determinants · CPC title
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.